Journals / Ulusal Cerrahi Dergisi / 2009 / Cilt: 25 - Sayı: 4

N-acetylcysteine can attenuate liver injury in obstructive jaundice in rats

N-asetilsistein sıçanlarda tıkanma sarılığına bağlı karaciğer hasarını azaltabilir

Pages
146–149
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: NAC can be useful in decreasing the paranchymal damage in the liver and suppress the plasma TNF-α levels in experimental obstructive jaundice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the effect of N-acetylcysteine (NAC) on the level of tumor necrosis factor-a (TNF-α) and liver parenchyma injury in an experimental rat model of obstructive jaundice.
📊
Key Findings & Data:Patients and Methods: Thirty-six Wistar-Albino rats weighing 250- 300 g were randomly divided into three groups of 12 animals in each, as sham-operated, bile duct ligated plus NAC-treated (treatment), bile duct ligated plus saline administered (control).
💡
Conclusion & Impact:Conclusion: NAC can be useful in decreasing the paranchymal damage in the liver and suppress the plasma TNF-α levels in experimental obstructive jaundice.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Asetilsistein · Modeller · hayvan

Abstract

Purpose: To investigate the effect of N-acetylcysteine (NAC) on the level of tumor necrosis factor-a (TNF-α) and liver parenchyma injury in an experimental rat model of obstructive jaundice. Patients and Methods: Thirty-six Wistar-Albino rats weighing 250- 300 g were randomly divided into three groups of 12 animals in each, as sham-operated, bile duct ligated plus NAC-treated (treatment), bile duct ligated plus saline administered (control). After the operation, the rats in treatment and control groups were administered NAC and saline, respectively. After 10 days of treatment, liver function tests were performed and plasma TNF-a levels were determined in all rats to assess the parenchymal damage. Results: Parenchymal damage and plasma TNF-α levels were significantly lower in the treatment group, compared with the control group. Conclusion: NAC can be useful in decreasing the paranchymal damage in the liver and suppress the plasma TNF-α levels in experimental obstructive jaundice.

Özet

Amaç: Tıkanma sarılıklı sıçanlarda N-Asetilsisteinin (NAS) plazma tümör nekrozis faktör alfa (TNF-α) düzeyleri üzerine ve karaciğer parenkim hasarına etkisini araştırmak. Gereç ve Yöntem: Ağırlıkları 250-300 g arasında değişen 36 adet Wistar-Albino cinsi sıçan sham operasyonu yapılan (sham grubu), koledok kanalı bağlanarak NAS tedavisi verilen (tedavi grubu) ve koledok kanalı bağlanan ama tedavi verilmeyen (kontrol grubu) olmak üzere 12'şerli üç gruba ayrıldı. Tedavi ve kontrol grubundaki sıçanlara ameliyat sonrası 10 gün süresince sırasıyla NAS veya serum fizyolojik uygulandı. On günlük tedaviyi takiben parenkim hasarını değerlendirmek için tüm sıçanların karaciğer fonksiyon testleri ve plazma TNF-a düzeyleri ölçüldü. Bulgular: Tedavi grubunda parenkim hasarının kontrol grubuna göre anlamlı olarak daha az olduğu ve plazma TNF-α düzeylerinin de anlamlı ölçüde düşük olduğu saptandı. Sonuç: NAS deneysel tıkanma sarılığında plazma TNF-α düzeylerinin baskılanması ve karaciğer parenkim hasarının azaltılmasında faydalı olabilir.

🔖

Cite This Article

MERSİN, H. H., AKBABA, M., BAŞKAN, E., BERBEROĞLU, A. U. (2009). N-acetylcysteine can attenuate liver injury in obstructive jaundice in rats. Ulusal Cerrahi Dergisi, Cilt: 25 - Sayı: 4, 146–149. https://ajindex.com/articles/325511

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 1988; 75: 216-219
  2. Holman JM Jr, Rikkers LF, Moody FG. Sepsis in the management of complicated biliary disorders. Am J Surg 1979; 138: 809-813
  3. Nehéz L, Andersson R. Compromise of immune function in obstructive jaundice. Eur J Surg 2002; 168: 315-328
  4. Margaritis VG, Filos KS, Michalaki MA, Scopa CD, Spiliopoulou I, Nikolopoulou VN, Vagianos CE. Effect of oral glutamine administration on bacterial translocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg 2005; 29: 1329- 1334
  5. Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 1998; 42: 293-299
  6. Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001; 31: 383-390
  7. Tsai LY, Lee KT, Tsai SM, Lee SC, Yu HS. Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice. Clin Chim Acta 1993; 215: 41-50
  8. Tsuji F, Miyake Y, Aono H, Kawashima Y, Mita S. Effects of bucillamine and Nacetyl- L-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin Exp Immunol 1999; 115: 26-31
  9. Verhasselt V, Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G, Goldman M. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NFkappaB inhibition. J Immunol 1999; 162: 2569-2574
  10. Rahman A, Kefer J, Bando M, Niles WD, Malik AB. E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol 1998; 275: 533-544
  11. Nakano H, Fujiwara Y, Kitamura N, Kumada K, Matsumiya A, Sakai H, Hatakeyama T, Yamaguchi M, Jaeck D. Susceptibility to lipopolysaccharide of cholestatic rat liver produced with bile duct ligation: assessments of the mitochondrial glutathione pool and the effects of N-acetylcysteine. Eur Surg Res 2000; 32: 148-154
  12. Assimakopoulos SF, Maroulis I, Patsoukis N, Vagenas K, Scopa CD, Georgiou CD, Vagianos CE. Effect of antioxidant treatments on the gut-liver axis oxidative status and function in bile duct-ligated rats. World J Surg 2007; 31: 20